Heparanase-1 is downregulated in chemoradiotherapy orbital rhabdomyosarcoma and relates with tumor growth as well as angiogenesis

MLA

Wei-Qiang Tang, et al. “Heparanase-1 Is Downregulated in Chemoradiotherapy Orbital Rhabdomyosarcoma and Relates with Tumor Growth as Well as Angiogenesis.” International Journal of Ophthalmology, vol. 15, no. 1, Jan. 2022, pp. 31–39. EBSCOhost, https://doi.org/10.18240/ijo.2022.01.05.

APA

Wei-Qiang Tang, Yan Hei, & Jing Lin. (2022). Heparanase-1 is downregulated in chemoradiotherapy orbital rhabdomyosarcoma and relates with tumor growth as well as angiogenesis. International Journal of Ophthalmology, 15(1), 31–39. https://doi.org/10.18240/ijo.2022.01.05

Chicago

Wei-Qiang Tang, Yan Hei, and Jing Lin. 2022. “Heparanase-1 Is Downregulated in Chemoradiotherapy Orbital Rhabdomyosarcoma and Relates with Tumor Growth as Well as Angiogenesis.” International Journal of Ophthalmology 15 (1): 31–39. doi:10.18240/ijo.2022.01.05.